Latest rare cancer News

AusBiotech and Medicines Australia gather industry leaders to accelerate action this International Women’s Day
Funding To Expand Australian Rare Cancer Portal
Chris’ Rare Sinus Cancer, Survival And Starting Again
Support for state-of-the-art cancer research projects
Newborn Jasper In Fight Of His Life To Beat Rare Cancer
5000 Cyclists Saddle Up In Fight Against Cancer
Ensuring access to rare cancer treatment for patients with neuroblastoma
$71 million for clinical trials and research into the best multidisciplinary models of primary care
Asbestos study highlights risk of ACT residents developing cancer
Victorians Gain Access to Cutting-Edge Precision Cancer Therapies Thanks to Landmark $10M Donation
Cost of whole-genome sequencing approaching current routine genetic testing in blood cancer
Cabozantinib now available for patients with non-clear cell renal cell carcinoma via the PBS
Inspiring contributions to cancer equity recognised through the Jeannie Ferris Award
Scientists exploring more targeted radiation for glioblastoma
7 Things To Know About Soft Tissue Sarcoma
How Research In Common Cancers Is Helping Rare Cancers
Unbreakable Amy Is Still Beating Cancer After 21 Years
AMA stands with Senator and allies for ban on genetic tests in life insurance
Chris’s message to others: “Screening can save your life.”
Rob’s Shedding some light on rare cancer
Cheaper medicines for advanced melanoma and multiple sclerosis
Closing in on the ultimate quest to regenerate insulin in pancreatic stem cells
$147.5 million for research into rare illnesses, multidisciplinary primary care, cardiovascular disease and diabetes
Professor Maher Gandhi: Life as clinician-scientist
Evaluation of MRFF’s Clinical Trials Activity initiative released
New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS
University joins European precision cancer medicine trial consortium
Ludwig Harvard study uncovers role of ultraviolet radiation in the development of a rare leukemia in the skin
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
This clinical trial is testing a new cure for a deadly rare blood cancer
Major funding for Manchester will help find new cancer treatments
Global study identifies genes that cause sarcoma
Precision medicine trial opens for rare adult and paedatric cancers
Cancer researchers across UK join forces to find drugs for rare cancers